Lithium and GSK3-β promoter gene variants influence white matter microstructure in bipolar disorder

Neuropsychopharmacology

Volumn 38, Issue 2, 2013, Pages 313-327

  Benedetti, Francesco ^a   Bollettini, Irene ^a   Barberi, Ignazio ^b   Radaelli, Daniele ^a   Poletti, Sara ^a   Locatelli, Clara ^a   Pirovano, Adele ^a   Lorenzi, Cristina ^a   Falini, Andrea ^a   Colombo, Cristina ^a   Smeraldi, Enrico ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

bipolar disorder; cingulum bundle; GSK3 ; lithium; white matter

Indexed keywords

GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM;

ADULT; ALLELE; ARTICLE; BIPOLAR DISORDER; BRAIN FUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; DEPRESSION; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; DISEASE DURATION; DNA POLYMORPHISM; EDUCATIONAL STATUS; ENZYME INHIBITION; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENE FREQUENCY; GENOTYPE; GRAY MATTER; HANDEDNESS; HEAD MOVEMENT; HETEROZYGOTE; HOMOZYGOTE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MANIA; NERVE CELL PLASTICITY; NERVE FIBER; OLIGODENDROGLIA; ONSET AGE; PRIORITY JOURNAL; PROMOTER REGION; SCHIZOPHRENIA; TREATMENT DURATION; UNCINATE FASCICULUS; WHITE MATTER;

ADULT; BIPOLAR DISORDER; FEMALE; GENETIC VARIATION; GLYCOGEN SYNTHASE KINASE 3; HUMANS; LITHIUM; MALE; MIDDLE AGED; NERVE FIBERS, MYELINATED; PROMOTER REGIONS, GENETIC;

EID: 84871429643     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2012.172     Document Type: Article

References (123)

1. Adler CM, Adams J, DelBello MP, Holland SK, Schmithorst V, Levine A et al (2006). Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study. Am J Psychiatry 163: 322-324.
2. Adli M, Hollinde DL, Stamm T, Wiethoff K, Tsahuridu M, Kirchheiner J et al (2007). Response to lithium augmentation in depression is associated with the glycogen synthase kinase 3-beta-50T/C single nucleotide polymorphism. Biol Psychiatry 62: 1295-1302.
3. Arnone D, McIntosh AM, Chandra P, Ebmeier KP (2008). Meta-analysis of magnetic resonance imaging studies of the corpus callosum in bipolar disorder. Acta Psychiatr Scand 118: 357-362.
4. Azim K, Butt AM (2011). GSK3beta negatively regulates oligodendrocyte differentiation and myelination in vivo. Glia 59: 540-553.
5. Bachmann RF, Schloesser RJ, Gould TD, Manji HK (2005). Mood stabilizers target cellular plasticity and resilience cascades: implications for the development of novel therapeutics. Mol Neurobiol 32: 173-202.
6. Bartzokis G (2011). Neuroglialpharmacology: white matter pathophysiologies and psychiatric treatments. Front Biosci 17: 2695-2733.
7. Bartzokis G, Lu PH, Stewart SB, Oluwadara B, Lucas AJ, Pantages J et al (2009). In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res 113: 322-331.
8. Basser PJ, Mattiello J, LeBihan D (1994). MR diffusion tensor spectroscopy and imaging. Biophys J 66: 259-267.
9. Bearden CE, van Erp TG, Dutton RA, Boyle C, Madsen S, Luders E et al (2011). Mapping corpus callosum morphology in twin pairs discordant for bipolar disorder. Cereb Cortex 21: 2415-2424.
10. Beaulieu JM (2012). A role for Akt and glycogen synthase kinase-3 as integrators of dopamine and serotonin neurotransmission in mental health. J Psychiatry Neurosci 37: 7-16.
11. Beaulieu JM, Gainetdinov RR, Caron MG (2009). Akt/GSK3 signaling in the action of psychotropic drugs. Annu Rev Pharmacol Toxicol 49: 327-347.
12. Beaulieu JM, Zhang X, Rodriguiz RM, Sotnikova TD, Cools MJ, Wetsel WC et al (2008). Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency. Proc Natl Acad Sci USA 105: 1333-1338.
13. Benedetti F, Giacosa C, Radaelli D, Poletti S, Dallaspezia S, Pozzi E et al (2012). Widespread changes of white matter microstructure in obsessive-compulsive disorder: Effect of drug status. Eur Neuropsychopharmacol (in press) http://dx.doi.org/10.1016/j. euroneuro.2012.07.002.
14. Benedetti F, Absinta M, Rocca MA, Radaelli D, Poletti S, Bernasconi A et al (2011a). Tract-specific white matter structural disruption in patients with bipolar disorder. Bipolar Disord 13: 414-424.
15. Benedetti F, Barbini B, Bernasconi A, Fulgosi MC, Campori E, Colombo C et al (2008). Lithium overcomes the influence of 5-HTTLPR gene polymorphism on antidepressant response to sleep deprivation. J Clin Psychopharmacol 28: 249-251.
16. Benedetti F, Bernasconi A, Lorenzi C, Pontiggia A, Serretti A, Colombo C et al (2004a). A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder. Neurosci Lett 355: 37-40.
17. Benedetti F, Dallaspezia S, Lorenzi C, Pirovano A, Radaelli D, Locatelli C et al (2012). Gene-gene interaction of glycogen synthase kinase 3-beta and serotonin transporter on human antidepressant response to sleep deprivation. J Affect Disord 136: 514-519.
18. Benedetti F, Poletti S, Radaelli D, Bernasconi A, Cavallaro R, Falini A et al (2010). Temporal lobe grey matter volume in schizophrenia is associated with a genetic polymorphism influencing glycogen synthase kinase 3-beta activity. Genes Brain Behav 9: 365-371.
19. Benedetti F, Radaelli D, Poletti S, Locatelli C, Falini A, Colombo C et al (2011b). Opposite effects of suicidality and lithium on gray matter volumes in bipolar depression. J Affect Disord 135: 139-147.
20. Benedetti F, Serretti A, Colombo C, Lorenzi C, Tubazio V, Smeraldi E (2004b). A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression. Neurosci Lett 368: 123-126.
21. Benedetti F, Serretti A, Pontiggia A, Bernasconi A, Lorenzi C, Colombo C et al (2005). Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta-50T/C SNP. Neurosci Lett 376: 51-55.
22. Benedetti F, Yeh PH, Bellani M, Radaelli D, Nicoletti MA, Poletti S et al (2011c). Disruption of white matter integrity in bipolar depression as a possible structural marker of illness. Biol Psychiatry 69: 309-317.
23. Blumenthal JD, Zijdenbos A, Molloy E, Giedd JN (2002). Motion artifact in magnetic resonance imaging: implications for automated analysis. Neuroimage 16: 89-92.
24. Bora E, Fornito A, Yucel M, Pantelis C (2010). Voxelwise meta-analysis of gray matter abnormalities in bipolar disorder. Biol Psychiatry 67: 1097-1105.
25. Boretius S, Escher A, Dallenga T, Wrzos C, Tammer R, Bruck W et al (2012). Assessment of lesion pathology in a new animal model of MS by multiparametric MRI and DTI. Neuroimage 59: 2678-2688.
26. Brambilla P, Bellani M, Yeh PH, Soares JC (2009). Myelination in bipolar patients and the effects of mood stabilizers on brain anatomy. Curr Pharm Des 15: 2632-2636.
27. Bullmore ET, Suckling J, Overmeyer S, Rabe-Hesketh S, Taylor E, Brammer MJ (1999). Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain. IEEE Trans Med Imaging 18: 32-42.
28. Carter CJ (2007). Multiple genes and factors associated with bipolar disorder converge on growth factor and stress activated kinase pathways controlling translation initiation: implications for oligodendrocyte viability. Neurochem Int 50: 461-490.
29. Chen G, Zeng WZ, Yuan PX, Huang LD, Jiang YM, Zhao ZH et al (1999). The mood-stabilizing agents lithium and valproate robustly increase the levels of the neuroprotective protein bcl-2 in the CNS. J Neurochem 72: 879-882.
30. Chiu CT, Chuang DM (2010). Molecular actions and therapeutic potential of lithium in preclinical and clinical studies of CNS disorders. Pharmacol Ther 128: 281-304.
31. Dallaspezia S, Lorenzi C, Pirovano A, Colombo C, Smeraldi E, Benedetti F (2011). Circadian clock gene Per3 variants influence the postpartum onset of bipolar disorder. Eur Psychiatry 26: 138-140.
32. de Bartolomeis A, Tomasetti C, Cicale M, Yuan PX, Manji HK (2012). Chronic treatment with lithium or valproate modulates the expression of Homer1b/c and its related genes Shank and Inositol 1,4,5-trisphosphate receptor. Eur Neuropsychopharma-col 22: 527-535.
33. de Sousa RT, van de Bilt MT, Diniz BS, Ladeira RB, Portela LV, Souza DO et al (2011). Lithium increases plasma brain-derived neurotrophic factor in acute bipolar mania: a preliminary 4-week study. Neurosci Lett 494: 54-56.
34. Dietschy JM, Turley SD (2004). Thematic review series: brain lipids. Cholesterol metabolism in the central nervous system during early development and in the mature animal. J Lipid Res 45: 1375-1397.
35. Dill J, Wang H, Zhou F, Li S (2008). Inactivation of glycogen synthase kinase 3 promotes axonal growth and recovery in the CNS. J Neurosci 28: 8914-8928.
36. Du J, Wei Y, Liu L, Wang Y, Khairova R, Blumenthal R et al (2010). A kinesin signaling complex mediates the ability of GSK-3beta to affect mood-associated behaviors. Proc Natl Acad Sci USA 107: 11573-11578.
37. Dubois J, Dehaene-Lambertz G, Perrin M, Mangin JF, Cointepas Y, Duchesnay E et al (2008). Asynchrony of the early maturation of white matter bundles in healthy infants: quantitative landmarks revealed noninvasively by diffusion tensor imaging. Hum Brain Mapp 29: 14-27.
38. Fancy SP, Baranzini SE, Zhao C, Yuk DI, Irvine KA, Kaing S et al (2009). Dysregulation of the Wnt pathway inhibits timely myelination and remyelination in the mammalian CNS. Genes Dev 23: 1571-1585.
39. Feigenson K, Reid M, See J, Crenshaw EB 3rd, Grinspan JB (2009). Wnt signaling is sufficient to perturb oligodendrocyte maturation. Mol Cell Neurosci 42: 255-265.
40. Forde JE, Dale TC (2007). Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol Life Sci 64: 1930-1944.
41. Gould TD, Manji HK (2005). Glycogen synthase kinase-3: a putative molecular target for lithium mimetic drugs. Neuropsy-chopharmacology 30: 1223-1237.
42. Grimes CA, Jope RS (2001a). CREB DNA binding activity is inhibited by glycogen synthase kinase-3 beta and facilitated by lithium. J Neurochem 78: 1219-1232.
43. Grimes CA, Jope RS (2001b). The multifaceted roles of glycogen synthase kinase 3beta in cellular signaling. Prog Neurobiol 65: 391-426.
44. Harsan LA, Poulet P, Guignard B, Steibel J, Parizel N, de Sousa PL et al (2006). Brain dysmyelination and recovery assessment by noninvasive in vivo diffusion tensor magnetic resonance imaging. J Neurosci Res 83: 392-402.
45. Herting MM, Maxwell EC, Irvine C, Nagel BJ (2011). The Impact of Sex, Puberty, and Hormones on white matter microstructure in adolescents. Cereb Cortex 22: 1979-1992.
46. Hill T, Lewicki P (2006). Statistics: methods and applications. A comprehensive reference for science, industry, and data mining. General Linear Models Chapter 18, StatSoft: Tulsa, OK, 245-276.
47. Houenou J, Wessa M, Douaud G, Leboyer M, Chanraud S, Perrin M et al (2007). Increased white matter connectivity in euthymic bipolar patients: diffusion tensor tractography between the subgenual cingulate and the amygdalo-hippocampal complex. Mol Psychiatry 12: 1001-1010.
48. Iitaka C, Miyazaki K, Akaike T, Ishida N (2005). A role for glycogen synthase kinase-3beta in the mammalian circadian clock. J Biol Chem 280: 29397-29402.
49. Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P et al (2009). Association of GSK3beta polymorphisms with brain structural changes in major depressive disorder. Arch Gen Psychiatry 66: 721-728.
50. Inkster B, Nichols TE, Saemann PG, Auer DP, Holsboer F, Muglia P et al (2010). Pathway-based approaches to imaging genetics association studies: Wnt signaling, GSK3beta substrates and major depression. Neuroimage 53: 908-917.
51. Italia J, Mukhopadhyaya R, Rajadhyaksha MS (2011). Differential display RT-PCR reveals genes associated with lithium-induced neuritogenesis in SK-N-MC cells. Cell Mol Neurobiol 31: 1021-1026.
52. Jenkinson M, Smith S (2001). A global optimisation method for robust affine registration of brain images. Med Image Anal 5: 143-156.
53. Jiang H, Guo W, Liang X, Rao Y (2005). Both the establishment and the maintenance of neuronal polarity require active mechanisms: critical roles of GSK-3beta and its upstream regulators. Cell 120: 123-135.
54. Jope RS (1999). Anti-bipolar therapy: mechanism of action of lithium. Mol Psychiatry 4: 117-128.
55. Jope RS (2003). Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends Pharmacol Sci 24: 441-443.
56. Keedwell PA, Chapman R, Christiansen K, Richardson H, Evans J, Jones DK (2012). Cingulum white matter in young women at risk of depression: the effect of family history and anhedonia. Biol Psychiatry 72: 196-302.
57. Kinoshita Y, Ohnishi A, Kohshi K, Yokota A (1999). Apparent diffusion coefficient on rat brain and nerves intoxicated with methylmercury. Environ Res 80: 348-354.
58. Kochunov P, Thompson PM, Lancaster JL, Bartzokis G, Smith S, Coyle T et al (2007). Relationship between white matter fractional anisotropy and other indices of cerebral health in normal aging: tract-based spatial statistics study of aging. Neuroimage 35: 478-487.
59. Kockeritz L, Doble B, Patel S, Woodgett JR (2006). Glycogen synthase kinase-3-an overview of an over-achieving protein kinase. Curr Drug Targets 7: 1377-1388.
60. Kondratov RV, Shamanna RK, Kondratova AA, Gorbacheva VY, Antoch MP (2006). Dual role of the CLOCK/BMAL1 circadian complex in transcriptional regulation. FASEB J 20: 530-532.
61. Kwok JB, Hallupp M, Loy CT, Chan DK, Woo J, Mellick GD et al (2005). GSK3B polymorphisms alter transcription and splicing in Parkinson's disease. Ann Neurol 58: 829-839.
62. Le Bihan D (2003). Looking into the functional architecture of the brain with diffusion MRI. Nat Rev Neurosci 4: 469-480.
63. Lebel C, Gee M, Camicioli R, Wieler M, Martin W, Beaulieu C (2012). Diffusion tensor imaging of white matter tract evolution over the lifespan. Neuroimage 60: 340-352.
64. Leckman JFSD, Thompson WD, Belanger A, Weissman MM (1982). Best estimate of lifetime psychiatric diagnosis: a methodological study. Arch Gen Psychiatry 39: 879-883.
65. Leyhe T, Eschweiler GW, Stransky E, Gasser T, Annas P, Basun H et al (2009). Increase of BDNF serum concentration in lithium treated patients with early Alzheimer's disease. J Alzheimers Dis 16: 649-656.
66. Lu LH, Zhou XJ, Keedy SK, Reilly JL, Sweeney JA (2011). White matter microstructure in untreated first episode bipolar disorder with psychosis: comparison with schizophrenia. Bipolar Disord 13: 604-613.
67. Lyoo IK, Dager SR, Kim JE, Yoon SJ, Friedman SD, Dunner DL et al (2010). Lithium-induced gray matter volume increase as a neural correlate of treatment response in bipolar disorder: a longitudinal brain imaging study. Neuropsychopharmacology 35: 1743-1750.
68. Manji HK, Drevets WC, Charney DS (2001). The cellular neurobiology of depression. Nat Med 7: 541-547.
69. Manji HK, Moore GJ, Rajkowska G, Chen G (2000). Neuroplasticity and cellular resilience in mood disorders. Mol Psychiatry 5: 578-593.
70. Matsuo K, Nielsen N, Nicoletti MA, Hatch JP, Monkul ES, Watanabe Y et al (2010). Anterior genu corpus callosum and impulsivity in suicidal patients with bipolar disorder. Neurosci Lett 469: 75-80.
71. McCulloch CE, Searle SR, Neuhaus JM (2008). Generalized, Linear, and Mixed Models. Second Edition John Wiley & Sons.
72. Mizutani R, Yamauchi J, Kusakawa S, Nakamura K, Sanbe A, Torii T et al (2009). Sorting nexin 3, a protein upregulated by lithium, contains a novel phosphatidylinositol-binding sequence and mediates neurite outgrowth in N1E-115 cells. Cell Signal 21: 1586-1594.
73. Monkul ES, Matsuo K, Nicoletti MA, Dierschke N, Hatch JP, Dalwani M et al (2007). Prefrontal gray matter increases in healthy individuals after lithium treatment: a voxel-based morphometry study. Neurosci Lett 429: 7-11.
74. Moore GJ, Cortese BM, Glitz DA, Zajac-Benitez C, Quiroz JA, Uhde TW et al (2009). A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patients. J Clin Psychiatry 70: 699-705.
75. Namekata K, Harada C, Guo X, Kimura A, Kittaka D, Watanabe H et al (2012). Dock3 stimulates axonal outgrowth via GSK-3beta-mediated microtubule assembly. J Neurosci 32: 264-274.
76. Nanavati D, Austin DR, Catapano LA, Luckenbaugh DA, Dosemeci A, Manji HK et al (2011). The effects of chronic treatment with mood stabilizers on the rat hippocampal post-synaptic density proteome. J Neurochem 119: 617-629.
77. Nichols TE, Holmes AP (2002). Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum Brain Mapp 15: 1-25.
78. Ogata T, Iijima S, Hoshikawa S, Miura T, Yamamoto S, Oda H et al (2004). Opposing extracellular signal-regulated kinase and Akt pathways control Schwann cell myelination. J Neurosci 24: 6724-6732.
79. Oldfield RC (1971). The assessment and analysis of handedness: the Edinburgh inventory. Neuropsychologia 9: 97-113.
80. Pende M, Fisher TL, Simpson PB, Russell JT, Blenis J, Gallo V (1997). Neurotransmitter-and growth factor-induced cAMP response element binding protein phosphorylation in glial cell progenitors: role of calcium ions, protein kinase C, and mitogen-activated protein kinase/ribosomal S6 kinase pathway. J Neurosci 17: 1291-1301.
81. Qiu D, Tan LH, Zhou K, Khong PL (2008). Diffusion tensor imaging of normal white matter maturation from late childhood to young adulthood: voxel-wise evaluation of mean diffusivity, fractional anisotropy, radial and axial diffusivities, and correlation with reading development. Neuroimage 41: 223-232.
82. Quiroz JA, Machado-Vieira R, Zarate CA Jr., Manji HK (2010). Novel insights into lithium's mechanism of action: neurotrophic and neuroprotective effects. Neuropsychobiology 62: 50-60.
83. Rajkowska G (2002). Cell pathology in bipolar disorder. Bipolar Disord 4: 105-116.
84. Rich BA, Fromm SJ, Berghorst LH, Dickstein DP, Brotman MA, Pine DS et al (2008). Neural connectivity in children with bipolar disorder: impairment in the face emotion processing circuit. J Child Psychol Psychiatry 49: 88-96.
85. Rueckert D, Sonoda LI, Hayes C, Hill DL, Leach MO, Hawkes DJ (1999). Nonrigid registration using free-form deformations: application to breast MR images. IEEE Trans Med Imaging 18: 712-721.
86. Russ C, Lovestone S, Powell JF (2001). Identification of sequence variants and analysis of the role of the glycogen synthase kinase 3 beta gene and promoter in late onset Alzheimer's disease. Molecular Psychiatry 6: 320-324.
87. Saxena K, Tamm L, Walley A, Simmons A, Rollins N, Chia J et al (2012). A preliminary investigation of corpus callosum and anterior commissure aberrations in aggressive youth with bipolar disorders. J Child Adolesc Psychopharmacol 22: 112-119.
88. Schermuly I, Fellgiebel A, Wagner S, Yakushev I, Stoeter P, Schmitt R et al (2010). Association between cingulum bundle structure and cognitive performance: an observational study in major depression. Eur Psychiatry 25: 355-360.
89. Schloesser RJ, Martinowich K, Manji HK (2011). Mood-stabilizing drugs: mechanisms of action. Trends Neurosci 35: 36-46.
90. Sexton CE, Mackay CE, Lonie JA, Bastin ME, Terriere E, O'Carroll RE et al (2010). MRI correlates of episodic memory in Alzheimer's disease, mild cognitive impairment, and healthy aging. Psychiatry Res 184: 57-62.
91. Sexton CE, McDermott L, Kalu UG, Herrmann LL, Bradley KM, Allan CL et al (2011). Exploring the pattern and neural correlates of neuropsychological impairment in late-life depression. Psychol Med 42: 1195-1202.
92. Small SA, Schobel SA, Buxton RB, Witter MP, Barnes CA (2011). A pathophysiological framework of hippocampal dysfunction in ageing and disease. Nat Rev Neurosci 12: 585-601.
93. Smith SM (2002). Fast robust automated brain extraction. Hum Brain Mapp 17: 143-155.
94. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE et al (2006). Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31: 1487-1505.
95. Smith SM, Jenkinson M, Woolrich MW, Beckmann CF, Behrens TE, Johansen-Berg H et al (2004). Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 23(Suppl 1): S208-S219.
96. Smith SM, Johansen-Berg H, Jenkinson M, Rueckert D, Nichols TE, Miller KL et al (2007). Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2: 499-503.
97. Smith SM, Nichols TE (2009). Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44: 83-98.
98. Song SK, Sun SW, Ju WK, Lin SJ, Cross AH, Neufeld AH (2003). Diffusion tensor imaging detects and differentiates axon and myelin degeneration in mouse optic nerve after retinal ischemia. Neuroimage 20: 1714-1722.
99. Song SK, Sun SW, Ramsbottom MJ, Chang C, Russell J, Cross AH (2002). Dysmyelination revealed through MRI as increased radial (but unchanged axial) diffusion of water. Neuroimage 17: 1429-1436.
100. Sprooten E, Sussmann JE, Clugston A, Peel A, McKirdy J, Moorhead TW et al (2011). White matter integrity in individuals at high genetic risk of bipolar disorder. Biol Psychiatry 70: 350-356.
101. Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W (2009). Lithium enhances the neuronal differentiation of neural progenitor cells in vitro and after transplantation into the avulsed ventral horn of adult rats through the secretion of brain-derived neurotrophic factor. J Neurochem 108: 1385-1398.
102. Sun SW, Liang HF, Trinkaus K, Cross AH, Armstrong RC, Song SK (2006). Noninvasive detection of cuprizone induced axonal damage and demyelination in the mouse corpus callosum. Magn Reson Med 55: 302-308.
103. Suzuki S, Kiyosue K, Hazama S, Ogura A, Kashihara M, Hara T et al (2007). Brain-derived neurotrophic factor regulates cholesterol metabolism for synapse development. J Neurosci 27: 6417-6427.
104. Takahashi M, Ono J, Harada K, Maeda M, Hackney DB (2000). Diffusional anisotropy in cranial nerves with maturation: quantitative evaluation with diffusion MR imaging in rats. Radiology 216: 881-885.
105. Taylor WD, Hsu E, Krishnan KR, MacFall JR (2004). Diffusion tensor imaging: background, potential, and utility in psychiatric research. Biol Psychiatry 55: 201-207.
106. Timm N, Kim K (2006). Univariate and Multivariate General Linear Models: Theory and Applications with SAS, Second Edition. Springer: Berlin/Heidelberg.
107. Tkachev D, Mimmack ML, Ryan MM, Wayland M, Freeman T, Jones PB et al (2003). Oligodendrocyte dysfunction in schizophrenia and bipolar disorder. Lancet 362: 798-805.
108. Uranova NA, Vostrikov VM, Orlovskaya DD, Rachmanova VI (2004). Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. Schizophr Res 67: 269-275.
109. van der Schot AC, Vonk R, Brans RG, van Haren NE, Koolschijn PC, Nuboer V et al (2009). Influence of genes and environment on brain volumes in twin pairs concordant and discordant for bipolar disorder. Arch Gen Psychiatry 66: 142-151.
110. Vik-Mo AO, Ferno J, Skrede S, Steen VM (2009). Psychotropic drugs up-regulate the expression of cholesterol transport proteins including ApoE in cultured human CNS-and liver cells. BMC Pharmacol 9: 10.
111. VonDran MW, Singh H, Honeywell JZ, Dreyfus CF (2011). Levels of BDNF impact oligodendrocyte lineage cells following a cuprizone lesion. J Neurosci 31: 14182-14190.
112. Walther S, Hugli S, Hofle O, Federspiel A, Horn H, Bracht T et al (2012). Frontal white matter integrity is related to psychomotor retardation in major depression. Neurobiol Dis 47: 13-19.
113. Wang S, Sdrulla AD, diSibio G, Bush G, Nofziger D, Hicks C et al (1998). Notch receptor activation inhibits oligodendrocyte differentiation. Neuron 21: 63-75.
114. Wang Z, Wang J, Li J, Wang X, Yao Y, Zhang X et al (2011). MEK/ERKs signaling is essential for lithium-induced neurite outgrowth in N2a cells. Int J Dev Neurosci 29: 415-422.
115. Wessa M, Houenou J, Leboyer M, Chanraud S, Poupon C, Martinot JL et al (2009). Microstructural white matter changes in euthymic bipolar patients: a whole-brain diffusion tensor imaging study. Bipolar Disord 11: 504-514.
116. Westlye LT, Walhovd KB, Dale AM, Bjornerud A, Due-Tonnessen P, Engvig A et al (2010). Life-span changes of the human brain white matter: diffusion tensor imaging (DTI) and volumetry. Cereb Cortex 20: 2055-2068.
117. Woolrich MW, Jbabdi S, Patenaude B, Chappell M, Makni S, Behrens T et al (2009). Bayesian analysis of neuroimaging data in FSL. Neuroimage 45(1 Suppl): S173-S186.
118. Yoshimura T, Arimura N, Kawano Y, Kawabata S, Wang S, Kaibuchi K (2006). Ras regulates neuronal polarity via the PI3-kinase/-Akt/GSK-3beta/CRMP-2 pathway. Biochem Biophys Res Commun 340: 62-68.
119. Yoshimura T, Kawano Y, Arimura N, Kawabata S, Kikuchi A, Kaibuchi K (2005). GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell 120: 137-149.
120. Yuskaitis CJ, Jope RS (2009). Glycogen synthase kinase-3 regulates microglial migration, inflammation, and inflammation-induced neurotoxicity. Cell Signal 21: 264-273.
121. Zhang A, Leow A, Ajilore O, Lamar M, Yang S, Joseph J et al (2012). Quantitative tract-specific measures of uncinate and cingulum in major depression using diffusion tensor imaging. Neuropsychopharmacology 37: 959-967.
122. Zhang W, Smith A, Liu JP, Cheung NS, Zhou S, Liu K et al (2009). GSK3beta modulates PACAP-induced neuritogenesis in PC12 cells by acting downstream of Rap1 in a caveolae-dependent manner. Cell Signal 21: 237-245.
123. Zhou FQ, Zhou J, Dedhar S, Wu YH, Snider WD (2004). NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron 42: 897-912.